NQF Endorses Additional Pulmonary Measure 

JAN 09, 2013

CONTACT: Erin Weireter

NQF Endorses Additional Pulmonary Measure

Washington, DC - the National Quality Forum (NQF) Board of Directors has endorsed a measure focused on mortality rates for patients hospitalized with chronic obstructive pulmonary disease (COPD). The measure was evaluated as part of NQF’s pulmonary and critical care measure endorsement project, which had 19 measures endorsed in July 2012.

NQF is a voluntary consensus standards-setting organization. Any party may request reconsideration of the endorsed quality measure listed below by submitting an appeal no later than February 7 (to submit an appeal, go to the NQF Measure Database). For an appeal to be considered, the notification must include information clearly demonstrating that the appellant has interests directly and materially affected by the NQF-endorsed recommendations and that the NQF decision has had (or will have) an adverse effect on those interests.

1893: Hospital 30-day, all-cause, risk-standardized mortality rate (RSMR) following chronic obstructive pulmonary disease (COPD) hospitalization (CCSM/Yale)

NQF operates under a three-part mission to improve the quality of American healthcare by: 

  • building consensus on national priorities and goals for performance improvement and working in partnership to achieve them;
  • endorsing national consensus standards for measuring and publicly reporting on performance; and
  • promoting the attainment of national goals through education and outreach programs.